Annual Securities Report — FY2025
What Kohjin Bio Co.,Ltd. reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-23View the original on EDINET
How much it says
47Typical
What moved here
20named for the first time
Its own wording
70terms
Which filing this is
5/ 5newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the consolidated fiscal year, sales and profit increased in the Tissue Culture Business. However, consolidated sales and profit declined because of a post-pandemic decline in infectious-disease-related products in the Microbiology Business and weak inbound patient numbers in the Cell Processing Business. The filing states that, following administrative action under the Act on Securing Safety of Regenerative Medicine in August 2025 and January 2026, the company will continue its manufacturing business while implementing corrective measures and steps to prevent recurrence.
Komori's summary of this document, not the document's own words.47Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 38 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
68
Detailed
42
Thin
62
Detailed
0
Almost nothing
0
Almost nothing
55
Typical
33
Thin
69
Detailed
55
Typical
50
Typical
R&D spend3億円Money spent making new things.
Cash left over-2億円Cash from the business, less what went into equipment.
Spent on equipment10億円Plants, machines — things meant to last.
Employees176Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.